---
title: Tocilizumab for Cystoid Macular Edema Secondary to Immune Recovery Uveitis
  in a Patient with Contraindications to Long-Term Systemic Corticosteroid
date: '2024-12-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39703613/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20241221170701&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'Purpose: To report a case of cystoid macular edema (CME) secondary to
  immune recovery uveitis (IRU) in a patient with previous history of cytomegalovirus
  (CMV) retinitis and leukemia, which was successfully treated with tocilizumab (TCZ),
  an interleukin-6 (IL-6) receptor antagonist. Method: The clinical records of the
  case were reviewed, focusing on demographics, image findings, and clinical course.
  Results: A 17-year-old female with a past medical history of T-cell acute lymphoblastic
  ...'
disable_comments: true
---
Purpose: To report a case of cystoid macular edema (CME) secondary to immune recovery uveitis (IRU) in a patient with previous history of cytomegalovirus (CMV) retinitis and leukemia, which was successfully treated with tocilizumab (TCZ), an interleukin-6 (IL-6) receptor antagonist. Method: The clinical records of the case were reviewed, focusing on demographics, image findings, and clinical course. Results: A 17-year-old female with a past medical history of T-cell acute lymphoblastic ...